Stocks
Immunome (IMNM) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -761.9% | -3 240% | -3 060% | -5 594% | ||||
| Changes by years, y/y, % | -2 478pp | +180pp | +100.4% | ||||||
Immunome. Net margin, %
Immunome. Net margin, changes, pp
Immunome (IMNM) Net margin US GAAP (quarter values) |
||||||||
| FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | LTM ? | |||
| Net margin, % | ? | -1 528% | -1 619% | -2 931% | -1 423% | -1 081% | -5 594% | |
| Changes by years, y/y, % | -1 398pp | -1 497pp | -510pp | +11 161pp | +447pp | |||
| Changes by quarters, q/q, % | +11 056pp | -91pp | -1 312pp | +1 508pp | +342pp | |||
